Department of Radiology, University of California, San Francisco, 505 Parnassus Ave, Long L200B, Box 0628, San Francisco, CA 94143, USA.
Radiology. 2010 Feb;254(2):564-76. doi: 10.1148/radiol.09090663.
To determine whether magnetic resonance (MR) imaging is influenced by genetic and cellular features of glioblastoma multiforme (GBM) aggressiveness.
In this HIPAA-compliant institutional review board-approved study, multiple enhancing and peritumoral nonenhancing stereotactic neurosurgical biopsy samples from treatment-naïve GBMs were collected prospectively, with guidance from cerebral blood volume (CBV) MR imaging measurements. By using monoclonal antibodies, tissue specimens were examined for microvascular expression, hypoxia, tumor and overall cellular density, and histopathologic features of GBM aggressiveness. Genetic expression patterns were investigated with RNA microarrays. Imaging and histopathologic variables were compared with the Welch t test and Pearson correlations. Microarray analysis was performed by using false discovery rate (FDR) statistics.
Tumor biopsy of 13 adult patients yielded 16 enhancing and 14 peritumoral nonenhancing specimens. Enhancing regions had elevated relative CBV and reduced relative apparent diffusion coefficient (ADC) measurements compared with peritumoral nonenhancing biopsy regions (P < .01). A positive correlation was found between relative CBV and all histopathologic features of aggressiveness (P < .04). An inverse correlation was found between relative ADC and all histopathologic features of aggressiveness (P < .05). RNA expression patterns between tumor regions were found to be significantly different (FDR < 0.05), with hierarchical clustering by biopsy region only.
These findings suggest MR imaging is significantly influenced by GBM genetic and cellular biologic features of aggressiveness and imply physiologic MR imaging may be useful in pinpointing regions of highest malignancy within heterogeneous tissues, thus facilitating histologic grading of primary glial brain tumors.
确定磁共振(MR)成像是否受多形性胶质母细胞瘤(GBM)侵袭性的遗传和细胞特征的影响。
在这项符合 HIPAA 规定的机构审查委员会批准的研究中,前瞻性地从未经治疗的 GBM 中采集了多个增强和瘤周非增强立体定向神经外科活检样本,并结合脑血容量(CBV)MR 成像测量进行指导。通过使用单克隆抗体,对组织标本进行微血管表达、缺氧、肿瘤和整体细胞密度以及 GBM 侵袭性的组织病理学特征的检查。采用 RNA 微阵列研究基因表达模式。通过 Welch t 检验和 Pearson 相关分析比较成像和组织病理学变量。微阵列分析采用错误发现率(FDR)统计。
对 13 名成年患者的肿瘤活检获得了 16 个增强和 14 个瘤周非增强活检标本。与瘤周非增强活检区相比,增强区的相对 CBV 升高,相对表观扩散系数(ADC)降低(P<0.01)。相对 CBV 与侵袭性的所有组织病理学特征呈正相关(P<0.04)。相对 ADC 与侵袭性的所有组织病理学特征呈负相关(P<0.05)。肿瘤区域之间的 RNA 表达模式存在显著差异(FDR<0.05),仅通过活检区进行层次聚类。
这些发现表明,MR 成像受 GBM 侵袭性的遗传和细胞生物学特征的显著影响,提示生理 MR 成像可能有助于在异质组织中精确定位恶性程度最高的区域,从而有助于对原发性神经胶质瘤的组织学分级。